8
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22021 |
ACHP
IKK-2 Inhibitor VIII |
IκB/IKK | NF-κB |
ACHP(IKK-2 Inhibitor VIII) 是一种新型具有选择性和高效性的 IKK 抑制剂,对IKK-α和IKK-β 具有抑制作用。ACHP 具有抗 HIV-1 活性,通过抑制 NF-κB 激活来抑制 HIV-1 长末端重复序列 (LTR) 驱动的基因表达,抑制 TNF-α 诱导的 NF-κB (p65)募集到 HIV-1 LTR。 | |||
T10809L |
CHPG hydrochloride
CHPG hydrochloride(170846-74-9 Free base) |
ERK; NF-κB; GluR | MAPK; Neuroscience; NF-κB |
CHPG hydrochloride 是 mGluR5 的选择性激动剂。 | |||
T10237 |
ACHP Hydrochloride
IKK-2 Inhibitor VIII |
IκB/IKK | NF-κB |
ACHP Hydrochloride (IKK-2 Inhibitor VIII) 是选择性的IKK-β抑制剂 (IC50=5.8 nM)。 | |||
T10808 |
CHPG sodium salt
|
NF-κB; GluR | Neuroscience; NF-κB |
CHPG sodium salt 是 mGluR5 的选择性激动剂,可激活 ERK 和 Akt 信号通路。 CHPG 钠盐可用于创伤性脑损伤的研究。 | |||
T10809 |
CHPG
|
Others | Others |
CHPG is a selective agonist of mGluR5. In BV2 microglial cells, it attenuates SO2-induced oxidative stress and inflammation through the TSG-6/NF-κB pathway. | |||
T77651 |
Tubulin polymerization-IN-47
|
Microtubule Associated | Cytoskeletal Signaling |
Tubulin polymerization-IN-47 是一种 tubulin 聚合抑制剂和有丝分裂抑制剂,具有抗肿瘤活性,对神经母细胞瘤癌细胞增殖具有抑制作用,对 Chp-134 和 Kelly 细胞系的IC50 分别为 7 和 12 nM。Tubulin polymerization-IN-47 是治疗肝癌、结肠癌、肺癌和乳腺癌的候选化合物。 | |||
T79645 |
Tubulin polymerization-IN-48
|
||
Tubulin polymerization-IN-48 (Compound 4k) 是一种中等强度破坏微管网络的微管蛋白聚合抑制剂。其对神经母细胞瘤癌细胞增殖的抑制效果显著,Chp-134 细胞系和 Kelly 细胞系的IC50值分别为79 nM和165 nM。 | |||
T35599 |
Neuropeptide Y (3-36) (human, rat) (trifluoroacetate salt)
|
||
Neuropeptide Y (NPY) (3-36) is a C-terminal fragment of NPY, a neuropeptide involved in controlling appetite, blood pressure, cardiac contractility, and intestinal secretion. NPY (3-36) is an endogenous peptide produced by cleavage of NPY by dipeptidyl peptidase 4 (DPP-4). It binds selectively to the NPY receptor Y2 (Ki = 0.41 nM in CHP 234 cells) over the Y1 receptor, where it does not bind at concentrations up to 1 μM. NPY (3-36) (0.1 nM) increases migration of human umbilical vein endothelial... |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03529 |
Chemotaxis inhibitory Protein, S. aureus (strain MRSA252), Recombinant (His)
CHIPS,Chemotaxis inhibitory protein,chp |
Staphylococcus aureus | P. pastoris (Yeast) |
Involved in countering the first line of host defense mechanisms. Specifically inhibits the response of human neutrophils and monocytes to complement anaphylatoxin C5a and formylated peptides, like N-formyl-methionyl-leucyl-phenylalanine (fMLP). Acts by binding directly to the C5a receptor (C5aR) and formylated peptide receptor (FPR), thereby blocking the C5a- and fMLP-induced calcium responses. Prevents phagocytosis of the bacterium. Chemotaxis inhibitory Protein, S. aureus (strain MRSA252), Re... | |||
TMPH-03528 |
Chemotaxis inhibitory Protein, S. aureus (strain NCTC 8325/PS47), Recombinant (His & Myc)
chp,Chemotaxis inhibitory protein,CHIPS |
Staphylococcus aureus | E. coli |
Involved in countering the first line of host defense mechanisms. Specifically inhibits the response of human neutrophils and monocytes to complement anaphylatoxin C5a and formylated peptides, like N-formyl-methionyl-leucyl-phenylalanine (fMLP). Acts by binding directly to the C5a receptor (C5aR) and formylated peptide receptor (FPR), thereby blocking the C5a- and fMLP-induced calcium responses. Prevents phagocytosis of the bacterium. Chemotaxis inhibitory Protein, S. aureus (strain NCTC 8325/PS... |